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OBJECTIVE: Pleural tuberculosis is themost frequently occurring formof extra pulmonary disease in adults. In up to 40%
of cases, the lung parenchyma is concomitantly involved, which can have an epidemiological impact. This study aims to
evaluate the pleural and systemic inflammatory response of patients with pleural or pleuropulmonary tuberculosis.
METHODS: Aprospective study of 39 patients with confirmed pleural tuberculosis. After thoracentesis, a high resolution
chest tomography was performed to evaluate the pulmonary involvement. Of the 39 patients, 20 exhibited only pleural
effusion, and high resolution chest tomography revealed active associated-pulmonary disease in 19 patients. The total
protein, lactic dehydrogenase, adenosine deaminase, vascular endothelial growth factor, interleukin-8, tumor necrosis
factor-a, and transforming growth factor-b1 levels were quantified in the patient serum and pleural fluid.
RESULTS: All of the effusions were exudates with high levels of adenosine deaminase. The levels of vascular
endothelial growth factor and transforming growth factor-b1 were increased in the blood and pleural fluid of all of
the patients with pleural tuberculosis, with no differences between the two forms of tuberculosis. The tumor
necrosis factor-a levels were significantly higher in the pleural fluid of the patients with the pleuropulmonary form
of tuberculosis. The interleukin-8 levels were high in the pleural fluid of all of the patients, without any differences
between the forms of tuberculosis.
CONCLUSION: Tumor necrosis factor-a was the single cytokine that significantly increased in the pleural fluid of the
patients with pulmonary involvement. However, an overlap in the results does not permit us to suggest that
cytokine is a biological marker of concomitant parenchymal involvement. Although high resolution chest
tomography can be useful in identifying these patients, the investigation of fast acid bacilli and cultures for M.
tuberculosis in the sputum is recommended for all patients who are diagnosed with pleural tuberculosis.
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INTRODUCTION
Pleural tuberculosis is the most common extra pulmonary
form of tuberculosis in adults, particularly in countries
where the prevalence of the disease is high or moderate (1-
3). Although pulmonary tuberculosis can be a manifestation
of primary infection, it is most commonly associated with
the reactivation of pre-existing foci (1,2,4). It is generally
accepted that pleural tuberculosis results from a late
hypersensitive reaction to the antigens of M. tuberculosis
subsequent to the rupture of a subpleural caseous focus
(1,2,4). The release of even a small number of bacilli from the
lungs to the pleural space triggers a series of immune
reactions that are mediated by T lymphocytes, which
produce cytokines and stimulate macrophages to form a
granuloma (4-7). These events trigger an inflammatory
process in the pleural cavity: vascular permeability
increases and an influx of leukocytes enter the pleural
space, resulting in the accumulation of fluid and cells,
which is a characteristic of the pleural exudates (1,2,6).
Cytokines are a group of polypeptides with multiple
biological functions that act with other inflammatory
mediators to coordinate the interaction between sensitized
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lymphocytes and macrophages to form granulomas (5-11).
Among the involved mediators, we highlight the impor-
tance of interleukin-8 (IL-8) (8-15), vascular endothelium
growth factor (VEGF) (8,9,16-18), tumor necrosis factor-a
(TNF-a) (8,9,11,17-20), and transforming growth factor-b1
(TGF-b1) (7,9,20,21), all of which are considered to be key
effectors in the inflammatory response of the pleural space
(4-6).
Although pleural and pulmonary lesions were previously
considered to be independent events, the advent of computed
tomography has demonstrated concomitant lesions in more
than 40% of cases (1,21-24). This concomitance may have an
epidemiological impact, given that many patients with
pleural tuberculosis are not adequately evaluated for intra-
thoracic involvement. This finding enables us to speculate
whether serum or pleural fluid inflammatory markers in
pleural tuberculosis could suggest associated active pulmon-
ary disease. The answer to this question is particularly
relevant if we consider the potential risk of Mycobacterium
tuberculosis transmission from these patients to contacts.
Therefore, this study compares the serum and pleural
fluid expression of inflammatory mediators in pleural
tuberculosis patients to evaluate whether pulmonary-asso-
ciated involvement influences the magnitude of the inflam-
matory response. We hypothesized that the more extensive
the injury, the greater the inflammatory response. If this
hypothesis is true, the inflammatory cytokines could be
increased both locally (pleural fluid) and in the serum as a
result of the pulmonary involvement.
METHODS
After approval by the local ethics committee, informed
consent was obtained from 39 pleural tuberculosis patients.
The patients were prospectively selected from the out-
patient clinic of Pulmonary Diseases (InCor/FMUSP), Sa˜o
Paulo, Brazil.
The diagnosis of pleural tuberculosis was based on the
presence of a granuloma (upon pleural biopsy) associated
with exudative effusion with increased adenosine deaminase
(ADA . 40 IU/L) and/or a culture of the pleural fluid or
fragment positive for Mycobacterium tuberculosis (1,2,25). After
thoracentesis, the patients underwent high resolution chest
tomography (HRCT) and were subdivided into two groups
based on the HRCT findings: pleuropulmonary (n = 19) or
only pleural involvement (n = 20). The tomographic abnorm-
alities that were suggestive of active pulmonary disease
included the following: multi-segmental consolidation over
the upper lung zones (homogenous opacity that reflected
granulomatous inflammation of the parenchyma), thick-
walled cavities (resulting from the coalescence of multiple
inflammatory foci that necrotized and drained into the
airways), centrilobular or confluent nodules, and the presence
of the tree-in-bud pattern, which reflects the endobronchial
dissemination of caseous necrosis and the granulomatous
inflammation that fills and surrounds the alveolar ducts and
respiratory bronchioli. Patients who had nonspecific tomo-
graphic findings or images of residual scarring were not
included in this series (23-25). HIV patients, patients
previously treated for tuberculosis, and patients undergoing
immunosuppressant therapy were also excluded.
Concomitant with thoracentesis, all of the patients under-
went peripheral venous puncture and tuberculin skin
tests. Pleural fluid samples were processed for cytology,
bacilloscopy, M. tuberculosis cultures, and to determine the
adenosine deaminase levels (Giusti modified method) (26).
Proteins (Biuret method) and lactic dehydrogenase (enzy-
matic method) were also quantified in the blood and pleural
fluid. Aliquots from both samples (serum and pleural fluid)
were immediately centrifuged (1,500 rpm for 10 minutes at
4 C˚), and the supernatant was stored at -80 C˚ for posterior
cytokine analyses.
VEGF, IL-8, TNF-a, and TGF-b1 were quantified using an
immunoenzymatic method (enzyme-linked immunosorbent
assay, ELISA) according to the manufacturer’s instructions
(R&D Systems Inc., Minneapolis, USA). The assays were
performed in triplicate, and the results are expressed as
means. The results were quantified by comparing the optic
density (450 nm filter) in the ELISA reader (Powerwave,
Biotek, USA) against a pre-established standard curve. The
minimal detection values for IL-8, VEGF, and TGF-b1 were
31 pg/mL, and the minimum detection value for TNF-a was
16 pg/mL. To evaluate the pleural inflammatory response,
the results were compared with those obtained from the
serum and pleural fluid of the patients with transudates that
were caused by heart failure (27).
Statistical analysis
The results of the inflammatory marker analysis were
compared using Student’s T-test or the Mann Whitney U-
test according to the distribution of the variables. The
SigmaStat 3.5 (SSI 2006, California, USA) program was used
for the statistical analyses, and the results are presented as
medians (IQ 25th – 75th); p#0.05 was considered to be
statistically significant.
RESULTS
Thirty-nine patients (35¡15 years) presented with pleural
effusions caused by tuberculosis, and 19 patients exhibited
concomitant parenchyma involvement. In the patients with
pleural effusion (n = 20), the detection of fast acid bacilli in
the sputum was negative. In the pleuropulmonary group
(n = 19), three patients exhibited positive fast acid bacilli in
sputum. In two patients in the pleural group and six
patients in the pleuropulmonary group, the response to the
skin test exhibited indurations that were greater than 5 mm.
Thus, the microbiological detection and the skin test
contributed little toward diagnosing active pulmonary
tuberculosis. The patients were not submitted to bronch-
oalveolar lavage because they had previously been diag-
nosed with pleural tuberculosis.
The HRCT findings that were considered to be suggestive
of active pulmonary disease met the following criteria: the
presence of centrilobular nodules (n = 14), confluent nodules
(n = 11), tree-in-bud pattern (n = 15), pulmonary consolida-
tion in the upper lung zones (n = 8), and thick-walled
cavities (n = 3). Some patients exhibited more than one of
these radiological changes.
Tuberculous pleural effusions were exudates with high
ADA levels according to Light’s criteria. Comparing with
transudates, the levels of all inflammatory markers were
higher in the pleural fluid of the tuberculosis patients (data
not shown). VEGF and TGF-b1 were increased to similar
levels in the blood and pleural fluid of the patients with
both forms of the disease. The TNF-a levels were signifi-
cantly higher in the pleural fluid of the patients with the
pleuropulmonary form of the disease; this difference
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represented the single parameter that was capable of
differentiating between the two forms. IL-8 was increased
in the pleural fluid of all the TB patients, and no differences
in the levels of IL-8 were observed between the two forms.
As expected, the protein and lactic dehydrogenase levels
were higher in the serum and pleural fluid, respectively
(Table 1; Figures 1 and 2).
DISCUSSION
The high expression of inflammatory mediators in the
pleural fluid of pleural tuberculosis patients allows us to
recognize the exudative inflammatory response at the site of
active disease. The increased levels of VEGF and TGF-b in
the serum of these patients reflect the systemic response
Table 1 - Results obtained in the patients with pleural effusion secondary to tuberculosis (n = 39). The data are expressed
as medians (25th and 75th percentiles).
Pleural fluid Blood p-value
Biochemical Analysis
Total proteins (g/dL) 5.3 (4.7–5.7) 7.8 (7.2–8.5) ,0.001
Lactic dehydrogenase (UI/L) 877 (572–1182) 503 (442–591) ,0.001
Adenosine deaminase (U/L) 115 (78.1–145.3)
Pleural fluid/Blood
Total proteins 0.6 (0.6–0.7)
Lactic dehydrogenase 1.8 (1.2–2.2)
Cytokine Analysis
Vascular endothelium growth factor (VEGF) 1364 (927–2120) 896 (288–1781) 0.014
Interleukin-8 (IL-8) 1583 (1239–1886) 31 (31–125) ,0.001
Tumor necrosis factor-a (TNF-a) 209 (37–498) 16 (16–475) 0.007
Transforming growth factor-b1 (TGF-b1) 647 (377–1027) 751 (486–1135) 0.439
Figure 1 - Biochemical analysis of the fluid and blood of the patients with tuberculous pleural effusions. The data are expressed as
medians: 25th and 75th percentiles (*p,0.05: fluid x blood).
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observed in cases of pleural tuberculosis. Although elevated
TNF-a levels in the pleural fluid was the single parameter
that was capable of differentiating between the two forms of
the disease, the overlapping results do not suggest that this
cytokine is a marker of pulmonary involvement.
Tuberculosis pleurisy is an acute and symptomatic
disease that invariably evolves with exudative pleural
effusions that are rich in cells and inflammatory mediators
(1,2,4,7-10). Although tuberculosis pleurisy can indicate a
manifestation of primary infection, it is most commonly
associated with the reactivation of preexisting foci (1,2,4).
Currently available laboratory methods frequently fail to
demonstrate a possible concomitance with active pulmon-
ary disease (1). In this regard, high resolution chest
tomography has been helpful in identifying pulmonary
lesions that are consistent with active disease in approxi-
mately 40% of pleural tuberculosis patients (20-24). This
finding has epidemiological implications, particularly if we
consider that these patients are potential sources of infection
and that their contacts are often not clinically or radiologi-
cally evaluated. Therefore, we hypothesized that the
patients with the pleuropulmonary form of tuberculosis
could exhibit a greater inflammatory response because of
the involvement of more than one anatomic site. This fact
presumably determines systemic repercussions that could
be detected by evaluating the serum and pleural inflamma-
tory mediators.
Our findings corroborate previously described reports of
increased inflammatory mediators in the pleural fluid of
patients with pleural tuberculosis, thereby providing evi-
dence of the compartmentalization of the inflammatory
response at the active disease site (10,13,20,27). During the
early phases of infection, after antigenic stimulation is
triggered by the mycobacteria, cytokines such as VEGF,
TNF-a, and IL-8 are transiently produced in vivo and alter
the pleura permeability; this event precedes the exudative
phase (20,28). However, the elevated serum levels of TNF-a
and TGF-b are thought to be related to prolonged antigenic
stimulation, similar to observations in patients with pul-
monary tuberculosis or late-diagnosed pleural tuberculosis
(28-30).
In pleural tuberculosis, many cytokines are produced
intracavitarially and modulate the inflammatory response
that is triggered by the mycobacteria or its antigens to limit
or aggravate the disease (7,19). Previous studies have
related the findings of high serum or PF levels of TNF-a,
TGF-b, and IL-8 to residual pleural thickening (19,20). TGF-
b is a mediator that is expressed in active infection and plays
a fundamental role in the fibrotic scaring process. TGF-b is a
key mediator in the immunopathogenesis of tuberculosis
because it is able to modify the production and function of
other cytokines, such as IL-1b and TNF-a, in addition to
modulating the functions of T lymphocytes and macro-
phages (7,20,29,30). In pleural tuberculosis, the excessive
Figure 2 - Cytokines in the fluid and blood of the patients with tuberculous pleural effusions. The data are expressed as medians: 25th
and 75th percentiles (*p,0.05: pleural fluid x blood; #p,0.05: pleural6pleuropulmonary).
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production of TGF-b is believed to be related to the clinical
progression of the disease, particularly in the physiopathol-
ogy of pleural thickening (29). TGF-b possesses proinflam-
matory activity in low concentrations (pleural tuberculosis
and healthy contacts of tuberculosis carries) and anti-
inflammatory activity in high concentrations (pulmonary
tuberculosis). We observed increased levels of TGF-b in the
pleural fluid and blood of tuberculosis patients. Although
higher TGF-b levels were observed in the pleuropulmonary
form, there was no statistical significance when compared to
the levels in patients with pleural disease.
Siawaya et al. (8) studied the cytokine and chemokine
profiles of patients with different forms of tuberculosis to
better understand the immunopathology of the disease and
identify the biological markers that differentiate the various
clinical forms of the disease. The authors concluded that
systemic inflammatory markers, such as IL-8, TNF-a, and
VEGF, are associated with pleural tuberculosis, whereas
elevated levels of the factors involved in cell-mediated
immunity, such as IL-12p40 and sCD40L, characterize
pulmonary tuberculosis.
In conclusion, the present study demonstrates an intense
intracavitary inflammatory response in the patients with
pleural tuberculosis independent of parenchymal involve-
ment. Although all of the cytokines were overexpressed in
the pleural fluid, only TNF-a was significantly increased in
the pleuropulmonary tuberculosis patients. This finding
could suggest a more pronounced inflammatory response
because of the concomitance of the anatomic sites involved.
However, TNF-a should not be considered to be a biological
marker of pulmonary-associated disease. Although HRCT
can be useful in identifying these patients, the identification
of fast acid bacilli and/or the culture for M. tuberculosis in the
sputum is recommended for all pleural tuberculosis patients.
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